Clinuvel Pharmaceuticals Market Cap

Clinuvel Pharmaceuticals has a market cap or net worth of $314.03 million as of June 20, 2025. Its market cap has decreased by -36.99% in one year.

Market Cap

314.03M

Enterprise Value

186.57M

Revenue

56.33M

Ranking

n/a

PE Ratio

13.09

Stock Price

$6.43

Market Cap Chart

Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 2.79M to 314.03M, an increase of 11,159.97%. That is a compound annual growth rate of 21.40%.

Market Cap History

Date	Market Cap	% Change
Jun 19, 2025	315.00M	-15.50%
Dec 31, 2024	372.77M	-31.82%
Dec 29, 2023	546.72M	-24.87%
Dec 30, 2022	727.74M	-25.56%
Dec 31, 2021	977.57M	14.90%
Dec 31, 2020	850.82M	-13.85%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.62B
Veradigm	755.74M
Elite Pharmaceuticals	715.74M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
American Oncology Network	414.48M
Glass House Brands	408.52M
CytoDyn	398.21M

Market Cap Rankings